Vaxcyte (PCVX) Market Cap 2020–2026

As of October 29, 2026, Vaxcyte had a market cap of $9.065 billion, which increased by 1.87% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Vaxcyte logo

Vaxcyte, Inc. (PCVX)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$9.065B ▲ 1.87%
Start of 2026
$6.04B ▲ 50.08%
1 Year Ago
$5.819B ▲ 55.78%
All-Time High
$14.674B ▼ 38.22%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Vaxcyte Market Cap History by Year and Month

Vaxcyte Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$9.065B▲ 50.08%
$9.065B▲ 10.04%
$8.238B▼ 6.32%
$8.794B▲ 12.67%
$7.805B▼ 6.96%
$8.389B▲ 13.03%
$7.422B▼ 9.91%
$8.238B▼ 1.49%
$8.363B▲ 3.48%
$8.082B▲ 15.24%
$7.013B▲ 16.11%
2025$6.04B▼ 40.92%
2024$10.223B▲ 71.10%
2023$5.975B▲ 57.78%
2022$3.787B▲ 200.08%
All market cap values reflect closing prices for the period shown.

📊 Vaxcyte Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:

  1. $14.87B
  2. $13.81B
  3. $12.85B
  4. $11.13B
  5. $10.21B
  6. $10.15B
  7. $9.97B
  8. $9.61B
  9. $9.34B
  10. $9.07B
  11. $8.79B
  12. $8.54B
  13. $8.06B
  14. $7.35B
  15. $7.1B
  16. $6.41B
  17. $5.49B
  18. $5.37B
  19. $5.25B
  20. $3.43B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.